Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;50(4):102056.
doi: 10.1016/j.jogoh.2020.102056. Epub 2021 Jan 2.

Cesarean scar pregnancy: Two case report and therapeutic management algorithm

Affiliations
Review

Cesarean scar pregnancy: Two case report and therapeutic management algorithm

Marie-Laure Legris et al. J Gynecol Obstet Hum Reprod. 2021 Apr.

Abstract

Objective: We aimed to present two cases of cesarean scar pregnancy (CSP) and a literature review to discuss their management.

Cases: We reported two cases of cesarean scar pregnancy (CSP) treated in Strasbourg's University Hospital between 2016 and 2018 and carried out an updated literature review concerning their treatment.

Results: The first case is a superficial implantation CSP managed by methotrexate (MTX) then ligation of the uterine arteries and echo-guided aspiration. The second case is a deep implantation CSP managed by MTX and then laparoscopic excision with clamping of the uterine arteries. In the literature, the most commonly used treatments are: MTX, echo-guided aspiration, and the combination of uterine artery embolization followed by echo-guided aspiration.

Conclusion: We established an algorithm in which CSP treatment by MTX can be considered alone if criteria are met. If not, surgery, chosen according to the depth of implantation, will be associated with MTX with a preventive hemostasis procedure by embolization or ligation of the uterine arteries.

Keywords: Algorithm of treatment; Cesarean scar pregnancy; Hemostatic procedure; Methotrexate; Surgery.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors report no declarations of interest.

Similar articles

Cited by

MeSH terms

Substances